Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pancreatic Neoplasms × talimogene laherparepvec × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Sarcoma 1 Paget Disease, Extramammary 1 Mycosis Fungoides 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Eccrine Porocarcinoma 1 Carcinoma, Signet Ring Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Carcinoma, Basosquamous 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Adenocarcinoma, Papillary 1

Interventions

Gemcitabine 17 Specimen Handling 11 130-nm albumin-bound paclitaxel 10 pembrolizumab 9 Magnetic Resonance Spectroscopy 8 Albumin-Bound Paclitaxel 7 Leucovorin 6 Fluorouracil 6 Biopsy 6 Taxes 5 Irinotecan 5 Cyclophosphamide 5 Cetuximab 5 fludarabine 4 Carboplatin 4 olaparib 3 dehydroftorafur 3 Radiosurgery 3 Oxaliplatin 3 zimberelimab 2 trastuzumab deruxtecan 2 quemliclustat 2 irinotecan sucrosofate 2 durvalumab 2 aldesleukin 2 Tadalafil 2 Pemetrexed 2 Immunoglobulin G 2 Erlotinib Hydrochloride 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡